MOLECULAR DYNAMICS SIMULATIONS OF SEVERAL SELECTED COMPOUNDS FROM THE HERBAL DATABASE OF INDONESIA RESULTS OF MOLECULAR DOCKING AGAINST DNA METHYLTRANSFERASE ENZYME
Keywords:Cancer, DNA Methyltransferase, Epigenetic, Herbal database Indonesia, Molecular dynamic simulation
Objective: This study aimed to investigate the interactions of DNA methyltransferase (DNMT) enzymes and potential ligands as DNMT inhibitors
through molecular dynamics simulations.
Methods: This study was conducted using tools in the form of hardware (primary and secondary computers) and software (OpenBabel, AutoDock
Tools, Amber MD, Amber Tools, VMD, PuTTY, LigandScout, and UCSF Chimera).
Results: Results of molecular docking of cassiamin C, procyanidin B2, epicatechin-4alphaent-8-ent-epicatechin, epicatechin-4beta-8-epicatechin-
3-O-gallate, neorhusflavanone, 3-O-galloylepigallocatechin -4beta-6-epicatechin-3-O-gallate, withanolide, 3-O-galloylepigallocatechin-4beta-6-
epigallocatechin-3-O-gallate, cyanidin-3-6â€³-caffeylsophoroside-5-glucoside, epifriedelinol, gallocatechin-4alpha-8-epicatechin, scutellarein-7-
glucosyl-1-4-rhamnoside, epigallocatechin-3-gallate (EGCG) (positive control), and sinefungin (co-crystal) compounds showed Î”G values âˆ’9.34,
âˆ’10.95, âˆ’7.95, âˆ’11.01, âˆ’8.78, âˆ’8.87, âˆ’11.49, âˆ’7.98, âˆ’5.92, âˆ’8.92, âˆ’9.17, âˆ’8.76, âˆ’9.70, and âˆ’9.11 kcal/mol, respectively. Cassiamin C, procyanidin B2,
epicatechin-4-beta-8-epicatechin-3-O-gallate, withanolide, and gallocatechin-4alpha-8-epicatechin compounds had lower Î”G than sinefungin (cocrystal)
and EGCG (positive control) compounds. The results of molecular dynamic simulation of seven selected compounds showed the best overall
activities were procyanidin B2, epicatechin-4beta-8-epicatechin-3-O-gallate, and gallocatechin-4alpha-8-epi-catechin compounds.
Conclusions: The best overall activities based on molecular docking and molecular dynamic simulation were procyanidin B2, epicatechin-4beta-
8-epicatechin-3-O-gallate, and gallocatechin-4alpha-8-epi-catechin compounds. Amino acid residues that are important for the activity of DNMT1
inhibitor are Phe1145, Glu1168, Met1169, Cys1191, Glu1266, Ala1579, and Val1580.
Maliya A. Cell changes Become Cancerous from the Point of View of
Molecular Biology. Vol. 1. Indonesia: Infokes; 2004. p. 1-7.
American Cancer Society. The History of Cancer. American Cancer
Society; 2014. p. 1-16. Available from: http://www.cancer.org/thehistory-
of-cancer-pdf. [Last accessed on 15 Sep 2016].
Luczak MW, JagodziÅ„ski PP. The role of DNA methylation in cancer
development. Folia Histochem Cytobiol 2006;44:143-54.
Mikeska T, Craig JM. DNA methylation biomarkers: Cancer and
beyond. Genes (Basel) 2014;5:821-64.
Lao TD, Le TA. Hypermethylated DNA as biomarker for nasopharyngeal
cancer detection. Asian J Pharm Clin Res 2018;11:68-71.
Wilakaputra IGNRB. Virtual Screenig of Indonesian Herbal Database
Inhibitor DNA Metiltransferase. Depok: Faculty of Pharmacy,
Universitas Indonesia; 2016.
Yoo CB, Jones PA. Epigenetic therapy of cancer: Past, present and
future. Nat Rev Drug Discov 2006;5:37-50.
Gnyszka A, Jastrzebski Z, Flis S. DNA methyltransferase inhibitors
and their emerging role in epigenetic therapy of cancer. Anticancer Res
Rius M, Lyko F. Epigenetic cancer therapy: Rationales, targets and
drugs. Oncogene 2012;31:4257-65.
Lyko F, Brown R. DNA methyltransferase inhibitors and the
development of epigenetic cancer therapies. J Natl Cancer Inst
Yen CY, Huang HW, Shu CW, Hou MF, Yuan SS, Wang HR, et al.
DNA methylation, histone acetylation and methylation of epigenetic
modifications as a therapeutic approach for cancers. Cancer Lett
Medina-Franco JL. Advances in computational approaches for
drug discovery based on natural products. Rev Latinoam Quim
Maldonado-Rojas W, Olivero-Verbel J, Marrero-Ponce Y.
Computational fishing of new DNA methyltransferase inhibitors from
natural products. J Mol Graph Model 2015;60:43-54.
Singh BN, Shankar S, Srivastava RK. Green tea catechin,
epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and
clinical applications. Biochem Pharmacol 2011;82:1807-21.
Gros C, Fahy J, Halby L, Dufau I, Erdmann A, Gregoire JM, et al.
DNA methylation inhibitors in cancer: Recent and future approaches.
Shilpi A, Parbin S, Sengupta D, Kar S, Deb M, Rath SK, et al.
Mechanisms of DNA methyltransferase-inhibitor interactions:
Procyanidin B2 shows new promise for therapeutic intervention of
cancer. Chem Biol Interact 2015;233:122-38.